KYFORA BIO
Live / Registered — Registered (as of 24 Dec 2024)
What this means for you
Registered since 24 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97372045
- Registration number
- 7626969
- Mark type
- Stylized text
- Filed
- 20 Apr 2022
- Published for opposition
- 26 Sept 2023
- Registered
- 24 Dec 2024
- Attorney of record
- David M. Tener, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Chemical preparations for medical use for research and for genetic diagnostics, namely, for the discovery, development and delivery of cell and gene therapies for treating genetic diseases; Diagnostic agents for medical use for research and for genetic diagnostics; Reagents for medical use for research and for genetic diagnostics; Chemical and biochemical diagnostic reagent test kits for medical and clinical use comprised of medical diagnostic preparations, agents and reagents for use in disease testing; Medicines for the treatment of genetic diseases
- Class 042 — Scientific and technological services: Analyses in the field of molecular biology; Analysis of the chemical composition of liquids; Chemical analysis; Chemical and biochemical analyses; Chemical engineering services; Chemical laboratory services; Chemical research; Chemical technology research; Computer-aided scientific testing of DNA samples for diagnostic purposes; Scientific research in the nature of conducting clinical trials for others for pharmaceutical and genetic products; Consultancy in the field of pharmaceutical research; Consulting in relation to research and development of transfections agents and agents, reagents and chemicals and biochemicals used in the field of genetics; Development of new products in the field of gene therapy; Development of pharmaceutical preparations and medicines; Development of pharmaceutical products; Testing and evaluation of chemicals; Genetic analyses for scientific research purposes; Industrial packaging design services; Inspection of pharmaceutical products; Laboratory research in the field of genetics; Laboratory research services concerning pharmaceutical products; Pharmaceutical product development services; Pharmaceutical research services; Provision of information concerning the results of clinical trials for pharmaceutical products; Quality evaluation of pharmaceutical products; Research and development for the pharmaceutical industry; Research and development of new products for third parties; Research in the field of pharmaceutical products; Scientific analyses and research in the field of transfection; Scientific development of transfection agents; Scientific research for medical purposes in the field of genetics and genetic engineering; Scientific research in the field of genetics and genetic engineering; Scientific research in the field of medicines; Scientific testing services in the field of genetics; Services of a genetic research laboratory, namely, genetic testing for scientific research purposes and development of gene therapies for medical purposes; Software design and computer software design in the field of scientific research and genetic analyses; Structural and functional analysis of genomes; Testing of chemical products; Testing on pharmaceutical products
Owner
- KYFORA BIO, LLC, Horsham, PA, US
- KYFORA BIO, LLC, Horsham, PA, US
- The Ott Group, Inc., Warrington, PA, US
- The Ott Group, Inc., Warrington, PA, US
Prosecution history
- 24 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 03 Dec 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Dec 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Dec 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Nov 2024 — USE AMENDMENT FILED
- 21 Nov 2024 — TEAS STATEMENT OF USE RECEIVED
- 18 Jul 2024 — DIVISIONAL PROCESSING COMPLETE
- 18 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jul 2024 — SOU EXTENSION 1 GRANTED
- 21 May 2024 — SOU EXTENSION 1 FILED
- 18 Jul 2024 — DIVISIONAL REQUEST RECEIVED
- 22 May 2024 — TEAS REQUEST TO DIVIDE RECEIVED
- 28 Jun 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 May 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED